Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001786949-24-000002
Filing Date
2024-04-12
Accepted
2024-04-12 15:44:43
Documents
1
Effectiveness Date
2024-04-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 7891
  Complete submission text file 0001786949-24-000002.txt   8982
Mailing Address 920 SW 6TH AVE SUITE 1200 PORTLAND OR 97204
Business Address 920 SW 6TH AVE SUITE 1200 PORTLAND OR 97204 312-752-8446
Sparrow Pharmaceuticals, Inc. (Filer) CIK: 0001786949 (see all company filings)

EIN.: 464189155 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-510516 | Film No.: 24841283